Home » Topics » BioWorld Science

BioWorld Science
RSS

SmithKline Beecham develops Lp-PLA2 inhibitors for atherosclerosis

Jan. 20, 1998

MS&D reveals new class of antimigraine agents

Jan. 20, 1998

Lilly acquires rights to Sibia's drug discovery technology

Jan. 20, 1998

Lilly discloses new agents for influenza

Jan. 20, 1998

Lexicon and ZymoGenetics sign functional genomics agreement

Jan. 20, 1998

Novel semisynthetic macrolides prepared at Abbott

Jan. 20, 1998

Inhale and Lilly to codevelop pulmonary delivery formulation

Jan. 20, 1998

Optex awarded Phase II SBIR grant

Jan. 20, 1998

AxyS launches technologies division

Jan. 20, 1998

MedImmune and SmithKline Beecham finalize vaccine agreement

Jan. 20, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...
Neuro deals aplenty: UCB’s $1B+ takeover of Neurona the latest
BioWorld
A flurry of deals focused on the neurological disease space in 2026 suggest large biopharma companies are searching for the next best therapeutics for everything...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...